Plasma immunoreactive calcitonin in lung cancer

Area of Science:

• Endocrinology
• Oncology
• Biochemistry

Background:

• Plasma calcitonin measurements are used in lung cancer diagnostics.
• Radioimmunoassay (RIA) artifacts can complicate accurate calcitonin level determination.

Purpose of the Study:

• To investigate plasma calcitonin levels in various lung cancer histopathological types.
• To identify and characterize potential artifacts in calcitonin RIA for lung cancer patients.

Main Methods:

• Radioimmunoassay (RIA) and immunoextraction for calcitonin measurement.
• Immunoadsorbent chromatography, gel filtration, and heat treatment for artifact characterization.
• Parallel assays using human and salmon calcitonin RIA systems.

Main Results:

• Apparent calcitonin elevation in 18% of squamous/anaplastic lung cancer patients was due to RIA artifacts.
• Unequivocal hypercalcitoninemia was found in 27% of small cell carcinoma/adenocarcinoma patients.
• Elevated calcitonin in these cases was predominantly a high molecular weight form.

Conclusions:

• Standard calcitonin RIA may yield false positives in certain lung cancer types.
• Unequivocal hypercalcitoninemia is associated with small cell carcinoma and adenocarcinoma.
• Characterization of calcitonin moieties is crucial for accurate interpretation in lung cancer.